UTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Universal Technical Institute Inc (UTI) is not a strong buy for a beginner, long-term investor at the moment. While the company has a recent partnership announcement that could enhance its training programs, the financial performance shows declining net income and EPS, and hedge funds are significantly selling. The technical indicators are mixed, and there are no strong proprietary trading signals to suggest immediate action. Given the investor's preference for long-term investment, it is better to hold off on buying until there are clearer positive trends in financial performance or trading signals.
The MACD is positive but contracting, RSI is neutral at 55.288, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 37.621, with key resistance at 39.627 and support at 35.616. Overall, the technical indicators suggest a mixed trend with no strong buy signal.
UTI announced a three-year partnership with Fuji Spray to enhance its training programs, which could improve student job readiness and attract more enrollments.
Hedge funds are selling heavily, with a 295.72% increase in selling activity over the last quarter. Insider selling by George W. Brochick, reducing his holdings by 13.6%, also raises concerns about confidence in the stock.
In Q1 2026, revenue increased by 9.64% YoY to $220.84M. However, net income dropped by 42.10% YoY to $12.83M, and EPS fell by 42.50% YoY to 0.23. Gross margin slightly declined to 49.99%, down 0.58% YoY, indicating profitability challenges.
No recent analyst rating or price target changes are available for UTI.
